🎞

I caught up with Tillmam this morningbat #DD24 to learn more about Myllia Biotechnology, what they were showcading this week, customer painpoints and why companies should work them.
Visit stand #B12 and talk to Tilmann Burckstummer, Christoph Neumayr and Henrik Schmidt and learn more about their powerful CROP-Seq (Perturb-Seq) technology enabling #geneticscreening for #target #discovery/ #validation/
🎤 Don't miss Tilmann Burckstummer Technology Spotlight on October 3 at 2.40 PM on "𝐃𝐮𝐚𝐥 𝐂𝐑𝐈𝐒𝐏𝐑 𝐬𝐜𝐫𝐞𝐞𝐧𝐬 𝐞𝐧𝐚𝐛𝐥𝐢𝐧𝐠 𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐭𝐢𝐨𝐧 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬."
And check out their THREE posters
📰 Poster 201: “𝐀 𝐠𝐞𝐧𝐨𝐦𝐞-𝐰𝐢𝐝𝐞 𝐂𝐑𝐎𝐏-𝐒𝐞𝐪 𝐬𝐜𝐫𝐞𝐞𝐧 𝐫𝐞𝐯𝐞𝐚𝐥𝐬 𝐦𝐞𝐝𝐢𝐚𝐭𝐨𝐫𝐬 𝐨𝐟 𝐓 𝐜𝐞𝐥𝐥 𝐬𝐢𝐠𝐧𝐚𝐥𝐢𝐧𝐠”
📰Poster 237: “𝐃𝐞𝐬𝐢𝐠𝐧 𝐨𝐟 𝐡𝐢𝐠𝐡𝐥𝐲 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 𝐬𝐠𝐑𝐍𝐀 𝐥𝐢𝐛𝐫𝐚𝐫𝐢𝐞𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐜𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐟𝐞𝐚𝐭𝐮𝐫𝐞 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬”
📰Poster 251: “𝐒𝐢𝐧𝐠𝐥𝐞-𝐜𝐞𝐥𝐥 𝐂𝐑𝐈𝐒𝐏𝐑 𝐬𝐜𝐫𝐞𝐞𝐧𝐬 𝐢𝐧 𝐩𝐫𝐢𝐦𝐚𝐫𝐲 𝐡𝐮𝐦𝐚𝐧 𝐓 𝐜𝐞𝐥𝐥𝐬 𝐢𝐝𝐞𝐧𝐭𝐢𝐟𝐲 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐬 𝐨𝐟 𝐓𝐡2 𝐜𝐞𝐥𝐥 𝐬𝐤𝐞𝐰𝐢𝐧𝐠”
Learn more about
💻 Myllia Biotechnology here myllia.com/
💻 #MylliaBio's CROP-Seq (Perturb-Seq) technology here lnkd.in/eBCE9gMp
🎞 Check out heir RUclips Channel here lnkd.in/ezVHhrCc
#RSKDD24 #RSKELRIG #RSKMyllia #MylliaBio #TeamMyllia #CRISPR #SingleCells #scRNAseq #FunctionalGenomics #Biotech #TargetID #TargetDiscovery #DrugDiscovery #DrugDiscovery2024 #DD2024 #London
Tara Shanks Sanj Kumar